François Sarasin

TL;DR: For most patients with cirrhosis seen in the daily practice, biannual screening to detect symptomless tumors accessible to surgical resection provides negligible benefit in life expectancy, and for well-targeted patients with the longest reported cirrhoses-related survival rate, screening may substantially increase mean life expectancy at lower costs.

TL;DR: Estimating the survival and graft‐saving of a strategy of primary resection and salvage transplantation according to variables that are to some extent predictable may be a rational way to cope with lengthening waiting lists.

TL;DR: The diagnostic yield of a standardized clinical evaluation of syncope was 76%, greater than reported previously in unselected patients, and electrocardiogram-based risk stratification was useful in guiding the use of specialized cardiovascular tests.

TL;DR: The authors’ work will be published in full at the 2016ESC Committee for Practice Guidelines: CPG conference in Washington, DC on 5 June 2016.